In people with thyroid eye disease, a blood test for TSI levels tends to match how inflamed their eyes are, while standard thyroid hormone tests do not.
Claim Context
Serum thyroid-stimulating immunoglobulin (TSI) levels at initial presentation correlate positively with clinical activity scores in patients with thyroid eye disease, suggesting TSI may reflect ongoing orbital inflammation better than standard thyroid function tests.
“TSI at presentation correlated with eyelid retraction, IOP (Pearson correlation, 0.369, P<=0.01), and CAS (Pearson correlation, 0.392, P = 0.029). These correlations were not significant for TSH, T3, and T4.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether TSI consistently outperforms TRAb and standard thyroid hormones in correlating with disease activity across diverse populations and assay methods.
A systematic review and meta-analysis of all prospective studies comparing TSI, TRAb, TSH, T3, and T4 levels with standardized CAS and imaging measures in thyroid eye disease, using individual patient data to calculate pooled correlation coefficients and ROC curves.
Whether using TSI to guide treatment initiation improves outcomes compared to using CAS alone.
A multicenter RCT of 200 patients with active thyroid eye disease, randomized to treatment decisions based on TSI >500% vs. CAS ≥3, with primary outcome of time to treatment escalation and secondary outcomes of visual function and quality of life over 12 months.
Whether TSI levels at diagnosis predict future changes in CAS over time, independent of thyroid hormone fluctuations.
A prospective cohort study following 150 patients with newly diagnosed thyroid eye disease, measuring TSI, TSH, T3, T4, and CAS every 3 months for 24 months, using multivariate models to isolate TSI's predictive value for CAS change.
Whether patients with active disease (CAS ≥3) have significantly higher TSI levels than those with inactive disease (CAS <3), matched for thyroid status.
A case-control study comparing TSI levels in 75 patients with active thyroid eye disease (CAS ≥3) and 75 matched controls with inactive disease (CAS <3), all with euthyroid status, controlling for age, sex, smoking, and duration of disease.
Whether TSI levels correlate with CAS at a single time point in a broad clinical population.
A cross-sectional analysis of TSI and CAS in 400 consecutive patients with thyroid eye disease across 5 centers, using standardized assays and blinded clinical assessments, with subgroup analysis by thyroid status.